Varex Imaging (VREX) Net Income towards Common Stockholders (2016 - 2026)
Varex Imaging's (VREX) quarterly Net Income towards Common Stockholders came in at -$8.0 million in Q2 2026, down 212.68% year-on-year from $7.1 million in Q2 2025, and down 433.33% on a QoQ basis from $2.4 million in Q1 2026.
Varex Imaging (VREX) Net Income towards Common Stockholders (2016 - 2026) Analysis & Trends
Varex Imaging (VREX) has 11 years of Net Income towards Common Stockholders data on file, last reported at -$8.0 million in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 212.68% year-over-year to -$8.0 million in Q2 2026; TTM through Apr 2026 was -$82.5 million, a 94.12% decrease from a year earlier, with the FY2025 full-year figure at -$69.9 million, down 44.72% from the prior year.
- Net Income towards Common Stockholders for Q2 2026 stood at -$8.0 million, down from $2.4 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for VREX reached as high as $31.2 million in Q3 2023 and fell as low as -$89.1 million in Q3 2025.
- Historically, Net Income towards Common Stockholders has averaged -$2.7 million across 5 years, with a median of $3.2 million in 2022.
- Across the five-year window, Net Income towards Common Stockholders slumped 6040.0% in 2025 and jumped 2500.0% in 2026, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at $3.2 million in 2022, then sank by 112.5% to -$400000.0 in 2023, then sank by 12650.0% to -$51.0 million in 2024, then soared by 123.92% to $12.2 million in 2025, then slumped by 165.57% to -$8.0 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$8.0 million in Q2 2026, $2.4 million in Q1 2026, and $12.2 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Varex Imaging | 458.64 Mn | 370.34 Mn | 72.60 Mn | -8.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -8.00 Mn |
| Jan 2, 2026 | 2.40 Mn |
| Oct 3, 2025 | 12.20 Mn |
| Jul 4, 2025 | -89.10 Mn |
| Apr 4, 2025 | 7.10 Mn |
| Jan 3, 2025 | -100,000.00 |
| Sep 27, 2024 | -51.00 Mn |
| Jun 28, 2024 | 1.50 Mn |
| Mar 29, 2024 | 1.60 Mn |
| Dec 29, 2023 | -400,000.00 |
| Sep 29, 2023 | 31.20 Mn |
| Jun 30, 2023 | 9.20 Mn |
| Mar 31, 2023 | 4.30 Mn |
| Dec 30, 2022 | 3.20 Mn |
| Sep 30, 2022 | 13.20 Mn |
| Jul 1, 2022 | 8.40 Mn |
| Apr 1, 2022 | 7.60 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Oct 1, 2021 | 8.80 Mn |
| Jul 2, 2021 | 12.20 Mn |